One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Breast Implant Market

[ 英語タイトル ] Breast Implant Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083302
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Allergan PLC
- Establishment Labs SA
- GC Aesthetics
- Groupe Sebbin SAS
- Laboratories Arion
- Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
- Polytech Health & Aesthetics GmbH
- Shanghai Kangning Medical Supplies Ltd
- Sientra Inc.

[Report Description]

The breast implant market is expected to register a CAGR of nearly 5.3% during the forecast period. The major factors for the growth of the breast implant market include the rising incidence of breast cancer, an increasing number of breast augmentation procedures, and technological advancements. Breast cancer is currently the leading cause of cancer-related deaths among women in the world's developing regions. According to the World Health Organization, in 2018, it is estimated that 627,000 women died from breast cancer, which is approximately 15% of all cancer deaths among women. Over 3.1 million American women have been affected by breast cancer as of March 2017. According to the American Cancer Society, in 2017, an estimated 252,710 new cases of invasive breast cancer were diagnosed among women. In addition, 63,410 cases of in situ breast carcinoma were diagnosed among women. Approximately 40,610 women and 460 men died from breast cancer in 2017 and therefore, the number of breast cancer cases is expected to increase in the coming years. Hence, the increase in breast cancer prevalence is a major factor contributing to the revenue growth of the breast implant market across the world.

Key Market Trends

Silicone Implant is the Drug Class Segment that is expected to be Fastest Growing Segment over the Forecast Period

Silicone gel-filled implants are the silicone shells filled with a plastic gel (silicone). The silicone gel-filled breast implants are approved for breast augmentation in women of age 22 or older and for breast reconstruction in women of any age. They are also used in revision surgeries, in order to correct or improve the result of an original surgery. Over the last 20 years, significant advances have been made to silicone gel implants. In fact, now surgeons are implanting the 7th and 8th generation of silicone breast implants. The newest silicone implants have a slightly higher fill (96% fill versus the previous generation's 85% fill) and more cross-linking of the silicone molecules, increasing the stiffness or cohesiveness of breast implants. These advances have helped in the growth of silicone breast implants. Furthermore, increasing breast cancer cases globally are boosting segment growth.

North America is Expected to Dominate the Market Over the Forecast Period

North America is found to hold a major share for the breast implant market and is expected to show a similar trend over the forecast period, without significant fluctuations. The major factor contributing to the growth of the market in the United States is the large demand for breast augmentation, coupled with the greater cost of the devices. Breast augmentation is the most popular cosmetic procedure that was being performed in the country, with around 290,467 patients opting for the surgery, according to new statistics released by the American Society of Plastic Surgeons. According to the American Society of Plastic Surgeons, in 2017, there were around 27,507 breast implant removals (augmentation patients only) performed. Thus, such a huge number of cases is expected to drive the growth of the breast implant market. For example, as per the, estimates in 2019, 268,600 new cases of invasive breast cancer are expected to be diagnosed in women along with 62,930 new cases of non-invasive breast cancer, in the United States. According to the American Society of Plastic Surgeons, in 2016, the average cost of breast augmentation surgery was USD 3,719 in the country. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of small and large market players. Some of the market players are Allergan Plc, Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson), Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Supplies Ltd, and Sientra Inc.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidence of Breast Cancer
4.2.2 Increasing Number of Breast Augmentation Procedures
4.2.3 Technological Advancements
4.3 Market Restraints
4.3.1 Post Complications and Risks Associated with Breast Implants
4.3.2 High Cost of Breast Implants
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Silicone Implant
5.1.2 Form-stable Implant
5.1.3 Saline Implant
5.1.4 Structured Saline Implant
5.2 By Application
5.2.1 Reconstructive Surgery
5.2.2 Cosmetic Surgery
5.3 By End User
5.3.1 Hospital
5.3.2 Cosmetology Clinic
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia - Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 Establishment Labs SA
6.1.3 GC Aesthetics
6.1.4 Groupe Sebbin SAS
6.1.5 Laboratories Arion
6.1.6 Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
6.1.7 Polytech Health & Aesthetics GmbH
6.1.8 Shanghai Kangning Medical Supplies Ltd
6.1.9 Sientra Inc.




Recommended reports